Quốc gia: Hoa Kỳ
Ngôn ngữ: Tiếng Anh
Nguồn: NLM (National Library of Medicine)
METFORMIN HYDROCHLORIDE (UNII: 786Z46389E) (METFORMIN - UNII:9100L32L2N)
REMEDYREPACK INC.
ORAL
PRESCRIPTION DRUG
Metformin is a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. ( 1) Severe renal impairment (eGFR below 30 mL/min/1.73 m 2) ( 4, 5.1) Hypersensitivity to metformin ( 4) Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma.( 4) Females and Males of Reproductive Potential: Advise premenopausal females of the potential for an unintended pregnancy. ( 8.3) Geriatric Use: Assess renal function more frequently. ( 8.5) Hepatic Impairment: Avoid use in patients with hepatic impairment. ( 8.7)
Metformin Hydrochloride Tablets, USP 500 mg Metformin Hydrochloride Tablets, USP 500 mg are blackberry flavored, white to off-white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one side ‘105’ on other side. NDC: 70518-3735-00 PACKAGING: 30 in 1 BLISTER PACK Store at 20°to 25°C (68°to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.] Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762 Store at 20°to 25°C (68°to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.]
Abbreviated New Drug Application
METFORMIN HYDROCHLORIDE- METFORMIN HYDROCHLORIDE TABLET REMEDYREPACK INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE METFORMIN HYDROCHLORIDE TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 1995 DOSAGE FORMS AND STRENGTHS Metformin Hydrochloride Tablets, USP: 500 mg, 850 mg, and 1000 mg ( 3) (1) ADVERSE REACTIONS For Metformin Hydrochloride Tablets, the most common adverse reactions (>5.0%) are diarrhea, nausea/vomiting, flatulence, asthenia, indigestion, abdominal discomfort, and headache. ( 6.1) (2) To report SUSPECTED ADVERSE REACTIONS, contact ScieGen at (855) 724-3436 or FDA at 1-800-FDA- 1088 or www.fda.gov/medwatch (2) DOSAGE AND ADMINISTRATION 2 DOSAGE AND ADMINISTRATION (12) SEE 17 FOR PATIENT COUNSELING INFORMATION AND FDA-APPROVED PATIENT LABELING. REVISED: 6/2023 FULL PRESCRIBING INFORMATION: CONTENTS* 3 DOSAGE FORMS AND STRENGTHS 6 ADVERSE REACTIONS 6.1 Clinical Studies Experience 6.2 Postmarketing Experience 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.3 Pharmacokinetics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 14 CLINICAL STUDIES 14.1 Metformin Hydrochloride Tablets 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied 16.2 Storage 17 PATIENT COUNSELING INFORMATION * Sections or subsections omitted from the full prescribing information are not listed. FULL PRESCRIBING INFORMATION 3 DOSAGE FORMS AND STRENGTHS Metformin Hydrochloride Tablets, USP are available as: Metformin Hydrochloride Tablets, USP 500 mg are blackberry flavored, white to off- white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one side ‘105’ on other side. Metformin Hydrochloride Tablets, USP 850 mg are blackberry flavored, white to off- white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one s Đọc toàn bộ tài liệu